Annual Gross Margin
64.91%
+6.04%+10.26%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual gross profit margin is 64.91%, with the most recent change of +6.04% (+10.26%) on December 31, 2023.
- During the last 3 years, PLX annual gross margin has fallen by -17.80% (-21.52%).
- PLX annual gross margin is now -22.05% below its all-time high of 83.27%, reached on December 31, 2015.
Performance
PLX Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Margin
53.37%
+23.55%+78.97%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly gross profit margin is 53.37%, with the most recent change of +23.55% (+78.97%) on September 30, 2024.
- Over the past year, PLX quarterly gross margin has increased by +0.67% (+1.27%).
- PLX quarterly gross margin is now -38.68% below its all-time high of 87.03%, reached on March 31, 2011.
Performance
PLX Quarterly Gross Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Margin Formula
Gross Margin = Gross Profit
Revenue ✕ 100%
Revenue ✕ 100%
PLX Gross Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.3% | +1.3% |
| 3 y3 years | -21.5% | +1.3% |
| 5 y5 years | -10.9% | +1.3% |
PLX Gross Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +13.1% | -35.3% | +243.4% |
| 5 y | 5-year | -21.5% | +13.1% | -37.9% | +243.4% |
| alltime | all time | -22.1% | +107.9% | -38.7% | +102.3% |
Protalix BioTherapeutics Gross Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 53.37%(+79.0%) |
| Jun 2024 | - | 29.82%(-2.5%) |
| Mar 2024 | - | 30.58%(+96.8%) |
| Dec 2023 | 64.91%(+10.3%) | 15.54%(-70.5%) |
| Sep 2023 | - | 52.70%(-36.1%) |
| Jun 2023 | - | 82.47%(+21.6%) |
| Mar 2023 | - | 67.82%(-6.0%) |
| Dec 2022 | 58.87%(+2.6%) | 72.18%(+44.0%) |
| Sep 2022 | - | 50.12%(-6.0%) |
| Jun 2022 | - | 53.31%(-14.7%) |
| Mar 2022 | - | 62.49%(-1.1%) |
| Dec 2021 | 57.37%(-30.6%) | 63.18%(-8.8%) |
| Sep 2021 | - | 69.28%(+162.8%) |
| Jun 2021 | - | 26.36%(-54.5%) |
| Mar 2021 | - | 57.91%(-32.6%) |
| Dec 2020 | 82.71%(+3.3%) | 85.88%(+17.0%) |
| Sep 2020 | - | 73.42%(-11.9%) |
| Jun 2020 | - | 83.34%(-1.0%) |
| Mar 2020 | - | 84.17%(+0.9%) |
| Dec 2019 | 80.08%(+10.0%) | 83.39%(+7.6%) |
| Sep 2019 | - | 77.51%(-0.6%) |
| Jun 2019 | - | 77.99%(-3.0%) |
| Mar 2019 | - | 80.41%(+3.1%) |
| Dec 2018 | 72.83%(+162.5%) | 78.00%(-7.6%) |
| Sep 2018 | - | 84.46%(+53.9%) |
| Jun 2018 | - | 54.88%(-2.8%) |
| Mar 2018 | - | 56.45%(-11.7%) |
| Dec 2017 | 27.74%(+218.5%) | 63.90%(+229.4%) |
| Sep 2017 | - | 19.40%(+47.8%) |
| Jun 2017 | - | 13.13%(-52.7%) |
| Mar 2017 | - | 27.73%(+347.3%) |
| Dec 2016 | 8.71% | 6.20%(-31.4%) |
| Sep 2016 | - | 9.04%(+70.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2016 | - | 5.31%(-76.9%) |
| Mar 2016 | - | 22.98%(-72.4%) |
| Dec 2015 | 83.27%(+1.4%) | - |
| Sep 2015 | - | 83.31%(+0.2%) |
| Jun 2015 | - | 83.16%(-0.2%) |
| Mar 2015 | - | 83.33%(+150.8%) |
| Dec 2014 | 82.12%(+7.6%) | 33.23%(-35.5%) |
| Sep 2014 | - | 51.50%(+28.0%) |
| Jun 2014 | - | 40.25%(-10.2%) |
| Mar 2014 | - | 44.83%(-28.5%) |
| Dec 2013 | - | 62.70%(+18.9%) |
| Sep 2013 | - | 52.75%(-7.4%) |
| Jun 2013 | - | 56.98%(-24.6%) |
| Mar 2013 | - | 75.53%(-103.2%) |
| Dec 2012 | 76.34%(+57.0%) | -2354.17%(-4297.1%) |
| Sep 2012 | - | 56.09%(-35.5%) |
| Jun 2012 | - | 87.02%(+34.7%) |
| Mar 2012 | - | 64.59%(+51.4%) |
| Dec 2011 | 48.62%(-20.3%) | 42.67%(-43.5%) |
| Sep 2011 | - | 75.47%(-112.1%) |
| Jun 2011 | - | -621.73%(-814.4%) |
| Mar 2011 | - | 87.03%(+53.2%) |
| Dec 2010 | 61.02%(-107.4%) | 56.80%(-14.7%) |
| Sep 2010 | - | 66.55%(+23.9%) |
| Jun 2010 | - | 53.72%(-106.5%) |
| Dec 2009 | -821.39%(-1171.3%) | -821.39%(-1891.5%) |
| Dec 2005 | 76.67%(+6.4%) | - |
| Dec 2004 | 72.09%(+194.1%) | - |
| Dec 1999 | 24.51%(+13.8%) | 45.85%(+445.2%) |
| Sep 1999 | - | 8.41%(-65.1%) |
| Jun 1999 | - | 24.13%(-5.5%) |
| Mar 1999 | - | 25.53% |
| Dec 1998 | 21.53% | - |
FAQ
- What is Protalix BioTherapeutics annual gross profit margin?
- What is the all time high annual gross margin for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual gross margin year-on-year change?
- What is Protalix BioTherapeutics quarterly gross profit margin?
- What is the all time high quarterly gross margin for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly gross margin year-on-year change?
What is Protalix BioTherapeutics annual gross profit margin?
The current annual gross margin of PLX is 64.91%
What is the all time high annual gross margin for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual gross profit margin is 83.27%
What is Protalix BioTherapeutics annual gross margin year-on-year change?
Over the past year, PLX annual gross profit margin has changed by +6.04% (+10.26%)
What is Protalix BioTherapeutics quarterly gross profit margin?
The current quarterly gross margin of PLX is 53.37%
What is the all time high quarterly gross margin for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly gross profit margin is 87.03%
What is Protalix BioTherapeutics quarterly gross margin year-on-year change?
Over the past year, PLX quarterly gross profit margin has changed by +0.67% (+1.27%)